Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial
- Resource Type
- Article
- Source
- In
eClinicalMedicine February 2024 68 - Subject
Primary Research Articles - Language
- ISSN
- 2589-5370